Insights Center
ML Strategies Viewpoints
Search
News & Press Releases
As the FDA Takes Center Stage During COVID, Big Changes Could Be Ahead
March 1, 2021 | The Street
Senior Director of ML Strategies Aaron L. Josephson participated in a Q&A interview with The Street about what to expect from the U.S. Food and Drug Administration (FDA) under the Biden Administration, potential picks to head the agency, and emergency-use authorizations.
Biden Admin Begins Massive Review, Reversal Of Trump Admin Regs, EOs
January 21, 2021 | Inside Health Policy
Senior Director of ML Strategies Aaron Josephson was quoted in Inside Health Policy on the Biden administration’s plans to reverse several Trump administration regulatory-focused executive orders, including two last-minute executive orders from the Trump administration on accountability in agency rulemaking and criminal penalties for violating certain agency regulations.
Communication Outlets: Challenges and Opportunities
January 5, 2021 | American Health Law Association
Mintz Member M. Daria Niewenhous co-authored an American Health Lawyers Association (AHLA) Business Law and Governance Practice Group Briefing that featured a Q&A discussion with two strategic communications and media experts, including Senior Vice President, Strategic Communications of ML Strategies Nancy J. Sterling, APR, Fellow PRSA, offering insights on best practices for proactive and reactive media communications for healthcare organizations.